INTERNATIONAL PATENT: ENTASIS THERAPEUTICS, INC., ALTARAC, DAVID FILES APPLICATION FOR "TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA CAUSED BY SUSCEPTIBLE ISOLATES OF ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX"

GENEVA, Nov. 25 -- ENTASIS THERAPEUTICS, INC. (35 Gatehouse DriveWaltham, MA 02451), ALTARAC, David (c/o Entasis Therapeutics, Inc.35 Gatehouse DriveWaltham, MA 02451) filed a patent application (PCT/US2024/029741) for "TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA CAUSED BY SUSCEPTIBLE ISOLATES OF ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX" on May 16, 2024. With publication no. WO/2025/239896, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ENTASIS THERAPEUTICS, INC. ...